1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Body Weight, Fetal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, S; Neerhof, MG; Qu, XW; Synowiec, S; Thaete, LG | 1 |
| Neerhof, MG; Thaete, LG | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Body Weight, Fetal
| Article | Year |
|---|---|
The significance of endothelin in platelet-activating factor-induced fetal growth restriction.
Topics: Animals; Endothelin A Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Weight; Gene Expression; Organ Size; Placenta; Platelet Activating Factor; Pregnancy; Pregnancy Outcome; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2012 |
Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Weight; Isoenzymes; Male; Ovary; Phospholipases A; Phospholipases A2; Placenta; Platelet Activating Factor; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Uterus | 2006 |